1
|
Zhu Y, Lu M, Gao F, Zhou C, Jia C, Wang J. Role of Tailor-Made Additives in Crystallization from Solution: A Review. Ind Eng Chem Res 2023. [DOI: 10.1021/acs.iecr.2c04025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/10/2023]
Affiliation(s)
- Yin Zhu
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, P. R. China
| | - Meijin Lu
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, P. R. China
| | - Feng Gao
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, P. R. China
| | - Chunli Zhou
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, P. R. China
| | - Chenyang Jia
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, P. R. China
| | - Jingtao Wang
- School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, P. R. China
| |
Collapse
|
2
|
Tian Y, Ma B, Liu C, Zhao X, Yu S, Li Y, Tian S, Pei H, Wang Z, Zuo Z, Wang Z. Integrated Solid-Phase Extraction, Ultra-High-Performance Liquid Chromatography-Quadrupole-Orbitrap High-Resolution Mass Spectrometry, and Multidimensional Data-Mining Techniques to Unravel the Metabolic Network of Dehydrocostus Lactone in Rats. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27227688. [PMID: 36431789 PMCID: PMC9696973 DOI: 10.3390/molecules27227688] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/05/2022] [Revised: 11/01/2022] [Accepted: 11/07/2022] [Indexed: 11/10/2022]
Abstract
Dehydrocostus lactone (DL) is among the representative ingredients of traditional Chinese medicine (TCM), with excellent anticancer, antibacterial, and anti-inflammatory activities. In this study, an advanced strategy based on ultra-high-performance liquid chromatography-quadrupole-Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) was integrated to comprehensively explore the metabolic fate of DL in rats. First, prior to data collection, all biological samples (plasma, urine, and feces) were concentrated and purified using solid-phase extraction (SPE) pre-treatment technology. Then, during data collection, in the full-scan (FS) data-dependent acquisition mode, FS-ddMS2 was intelligently combined with FS-parent ion list (PIL)-dynamic exclusion (DE) means for targeted monitoring and deeper capture of more low-abundance ions of interest. After data acquisition, data-mining techniques such as high-resolution extracted ion chromatograms (HREICs), multiple mass defect filters (MMDFs), diagnostic product ions (DPIs), and neutral loss fragments (NLFs) were incorporated to extensively screen and profile all the metabolites in multiple dimensions. As a result, a total of 71 metabolites of DL (parent drug included) were positively or tentatively identified. The results suggested that DL in vivo mainly underwent hydration, hydroxylation, dihydrodiolation, sulfonation, methylation, dehydrogenation, dehydration, N-acetylcysteine conjugation, cysteine conjugation, glutathione conjugation, glycine conjugation, taurine conjugation, etc. With these inferences, we successfully mapped the "stepwise radiation" metabolic network of DL in rats, where several drug metabolism clusters (DMCs) were discovered. In conclusion, not only did we provide a refined strategy for inhibiting matrix effects and fully screening major-to-trace metabolites, but also give substantial data reference for mechanism investigation, in vivo distribution visualization, and safety evaluation of DL.
Collapse
Affiliation(s)
- Yingying Tian
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Beibei Ma
- Research Institute of Beijing Tongrentang Co., Ltd., Beijing 100079, China
| | - Chuang Liu
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Xinyue Zhao
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Shangyue Yu
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Yilin Li
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Shiqiu Tian
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Hailuan Pei
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
| | - Zijian Wang
- Research Institute of Beijing Tongrentang Co., Ltd., Beijing 100079, China
| | - Zeping Zuo
- Research Institute of Beijing Tongrentang Co., Ltd., Beijing 100079, China
- Correspondence: (Z.Z.); (Z.W.)
| | - Zhibin Wang
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
- Research Institute of Beijing Tongrentang Co., Ltd., Beijing 100079, China
- Correspondence: (Z.Z.); (Z.W.)
| |
Collapse
|
3
|
Stanisz M, Klapiszewski Ł, Moszyński D, Stanisz BJ, Jesionowski T. Evaluation of cilazapril release profiles with the use of lignin-based spherical particles. J Drug Deliv Sci Technol 2022. [DOI: 10.1016/j.jddst.2022.103636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Performance Evaluation of a Novel Biosourced Co-Processed Excipient in Direct Compression and Drug Release. Polymers (Basel) 2021; 13:polym13060988. [PMID: 33807048 PMCID: PMC8004800 DOI: 10.3390/polym13060988] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 03/16/2021] [Accepted: 03/19/2021] [Indexed: 11/17/2022] Open
Abstract
This study exposes the potential usefulness of a new co-processed excipient, composed of alginic acid and microcrystalline cellulose (Cop AA-MCC), for the preparation of immediate drug release tablets by direct compression. Evaluation of the physical and mechanical properties as well as the disintegration behavior of Cop AA-MCC in comparison to commercial co-processed excipients (Cellactose®, Ludipress®, Prosolv® SMCC HD90 and Prosolv® ODT) and to the physical mixture of the native excipients (MCC and AA), was carried out. The obtained results illustrate the good performance of Cop AA-MCC in terms of powder flowability, tablet tensile strength, compressibility, and disintegration time. Although, this new co-processed excipient showed a slightly high lubricant sensitivity, which was explained by its more plastic than fragmentary deformation behavior, it presented a low lubricant requirement due to the remarkably low ejection force observed during compression. Compression speed and dwell time seemed not to affect significantly the tabletability of Cop AA-MCC. The study exposed evenly the performance of Cop AA-MCC compared to Prosolv® ODT, in terms of tabletability and dissolution rate of Melatonin. Cop AA-MCC presented comparable hardness, lower dilution potential, higher lubricant sensitivity, lower ejection force, and faster Melatonin's release time than Prosolv® ODT. In summary, Cop AA-MCC exhibited interesting physical, mechanical, and biopharmaceutical properties, which demonstrate its concurrence to commercially available co-processed excipients. Furthermore, the simplicity of its composition and the scalability of its elaboration makes this multifunctional excipient highly recommended for direct compression.
Collapse
|